Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Opigolix (ASP-1707) is an orally available gonadotropin-releasing hormone (GnRH) receptor antagonist for the study of endometriosis-related pain, rheumatoid arthritis, and uterine fibroids.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 67,500 |
5 mg | 在庫あり | ¥ 166,000 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 349,000 |
50 mg | 在庫あり | ¥ 454,500 |
100 mg | 在庫あり | ¥ 633,500 |
説明 | Opigolix (ASP-1707) is an orally available gonadotropin-releasing hormone (GnRH) receptor antagonist for the study of endometriosis-related pain, rheumatoid arthritis, and uterine fibroids. |
別名 | ASP-1707 |
分子量 | 544.5 |
分子式 | C25H19F3N4O5S |
CAS No. | 912587-25-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Opigolix 912587-25-8 GPCR/G Protein GNRH Receptor opigolix ASP-1707 Inhibitor inhibitor inhibit